Synthetic Exposure to Private Companies: How It Works

Synthetic exposure to private companies refers to financial instruments, such as pre-IPO perpetual futures, SPV-backed tokens, and equity swaps, that track a private firm's implied valuation without transferring ownership, equity rights, or IPO allocation to the holder. You gain price exposure. You do not gain a stake.

By mid-2026, over $2.2 billion in cumulative volume had flowed through SpaceX perpetual contracts alone before the company ever listed on a public exchange. That distinction sounds simple, but the market has become very good at blurring it. Here is what each structure actually does and what you are really holding.

What Is Synthetic Exposure to Private Companies?

The key word is "synthetic." A synthetic instrument is engineered to behave like the underlying asset from a price perspective, while deliberately decoupling the legal and governance rights that come with real ownership.

Three things are always absent from synthetic exposure, regardless of the structure:

• Equity ownership: You are not a shareholder
• Voting rights: You have no say in company decisions
• IPO allocation: Your position does not guarantee shares when the company goes public

What you do get is exposure to the price movement of the reference asset. If the implied valuation of a private company rises, your synthetic position benefits. If it falls, your position loses. The economic outcome mimics ownership. The legal reality does not.

Why Synthetic Exposure Exists

Companies are staying private much longer than they used to.

According to Jay Ritter's IPO dataset at the University of Florida, the median age of a company at IPO was around 8 years in the mid-1990s. By 2024, that figure had risen to 14 years, and it was 12 years in 2025.

The consequence is that the bulk of a company's value creation, the phase where a $10 billion startup becomes a $200 billion giant, now happens entirely out of reach for ordinary investors.

OpenAI was founded in 2015. SpaceX was founded in 2002. Neither has been publicly tradable until recently, and even now, access remains gated.

Traditional routes to private market exposure require either:

• Accredited investor status (net worth exceeding $1 million, or income above $200,000/year in the US)
• Institutional capital through VC funds, PE funds, or secondary platforms like Forge Global and EquityZen, often with minimum investments of $50,000 or more
• Employee equity through employment at the company itself

For everyone outside these categories, synthetic instruments represent the only operationally accessible path to price exposure on private companies. That demand is real, and the market has responded.

3 Main Structures Of Synthetic Exposure to Private Companies

There is no single product called "synthetic exposure." The term covers three distinct instrument types, each with different mechanics, risk profiles, and accessibility.

Pre-IPO perpetual futures

Pre-IPO perpetual futures are synthetic derivative contracts that create a continuous, 24/7 trading market for the implied valuation of a private company before it ever lists on a public exchange.

How they work:

A perpetual futures contract has no expiry date. Positions are maintained through a funding rate mechanism:

• If the contract trades above its mark price, longs pay shorts.
• If it trades below, shorts pay longs.

This keeps the contract price anchored near the implied reference valuation.

The mark price itself is derived from oracle feeds, typically based on secondary market transaction data, recent funding round valuations, or aggregated market-implied estimates of what the company is worth per share.

Who offers them:

As of June 2026, pre-IPO perp markets have expanded rapidly across both decentralized and centralized venues:

• Decentralized: Hyperliquid (via its HIP-3 permissionless framework, with builders Trade.xyz and Ventuals)
• Centralized: Binance (launched May 2026), Coinbase International (launched June 3, 2026), OKX, Gate.io, Kraken

Real-world accuracy:

When Cerebras Systems (CBRS) debuted on Nasdaq, Hyperliquid's pre-IPO perpetual had already priced it within 1.3% of the $350 opening price – a data point widely cited as evidence that these markets can generate credible valuation signals.

For SpaceX's June 12, 2026 IPO, the SPCX contract was trading at an aggregated VWAP of $155 across venues, against a $135 IPO price, reflecting a premium, but with over $215 million in open interest and $2.2 billion in cumulative volume, showing substantial market participation.

What you actually hold:

Price exposure only. When the company IPOs, your pre-IPO perp position typically transitions into a standard perpetual futures contract. It does not convert into shares.

SPV-backed tokenized equity

SPV-backed tokens occupy a middle ground between pure synthetic derivatives and real equity. They are closer to ownership in structure, but they are still not direct equity.

How they work:

A Special Purpose Vehicle (SPV) acquires actual shares of the private company, typically through secondary market purchases from early employees or existing investors. The SPV then issues digital tokens that represent a pro-rata claim on the assets held within that vehicle.

You are not on the company's cap table. You hold a claim on the SPV, which in turn holds the shares. The number of layers between you and the underlying equity matters enormously when things go wrong.

Examples in the market (2026):

• AngelList USVC Fund: Retail-accessible fund covering OpenAI, Anthropic, and xAI, with a $500 minimum entry point
• Robinhood Ventures Fund I: Invested $75 million into OpenAI; retail investors can buy shares in the fund to gain indirect exposure
• PreStocks: Tokenized single-asset offerings for specific private companies

The disavowal risk:

This is the critical risk specific to SPV-backed products that does not exist in pure synthetic derivatives. A company can explicitly prohibit SPVs from acquiring its stock, and if it does, the entire token structure may become invalid.

In May 2026, both OpenAI and Anthropic publicly disavowed unauthorized token products claiming to offer access to their shares. Anthropic updated its investor-warning page, stating that any unapproved products linking tokens to its equity should be treated with extreme caution, and confirmed it had banned SPVs from acquiring its stock.

What you actually hold:

An indirect claim on an SPV. Your exposure is subject to counterparty risk with the SPV operator, and it can be structurally invalidated by the underlying company itself.

Equity swaps

Equity swaps are the oldest and most technically rigorous form of synthetic equity exposure and the one least accessible to retail investors.

How they work:

An equity swap is a bilateral OTC (over-the-counter) contract negotiated between two parties, typically under an ISDA Master Agreement.

• One party, the receiver, gets the total return of a reference equity asset (price appreciation plus any income).
• The other party, the payer, receives a fixed or floating interest rate in exchange.

No shares change hands. Settlement occurs in cash, based on the difference between the two legs at agreed intervals (typically quarterly).

In the context of private companies, the reference asset is the implied valuation of the firm, often derived from recent funding rounds or secondary market data. Because private companies have no public market price, determining fair value for swap settlement is significantly more complex than for public equity swaps.

Who uses them:

Equity swaps on private companies are used almost exclusively by institutional players, including hedge funds, family offices, and large asset managers. Key reasons include:

• Avoiding transfer restrictions: Swaps provide economic exposure without triggering the share transfer restrictions common in private company shareholder agreements
• Off-balance-sheet leverage: The notional value of the swap does not require full capital outlay, enabling leveraged exposure with lower upfront capital
• Regulatory flexibility: In some jurisdictions, synthetic positions via swaps avoid certain reporting thresholds that direct ownership would trigger

What you actually hold:

A contractual claim on the return differential. No equity rights, no governance rights, and full counterparty exposure to the swap dealer.

What You Actually Hold – Rights Breakdown

Every form of synthetic exposure delivers price tracking. None delivers ownership. The table below maps out what each structure provides and what it explicitly does not.

In January 2026, the SEC released formal guidance clarifying that tokenized securities fall into two distinct categories:

• Those issued or authorized by the underlying company (which can represent true equity)
• Those created by third parties without issuer involvement

The latter, the SEC stated, typically provide only synthetic exposure or custodial entitlements and fall fully under traditional securities and derivatives rules.

This distinction has direct consequences.

A pre-IPO perpetual futures contract does not require company authorization. It references the company's implied valuation, but no shares change hands, and no company approval is needed.

An SPV token, by contrast, depends on the SPV actually holding legitimate shares. If the company disavows the structure, as both OpenAI and Anthropic did in May 2026, the legal and economic foundation of the token can collapse.

Synthetic Exposure vs Direct Private Equity Ownership

The comparison is useful not to evaluate which is "better," but to understand what synthetic instruments are actually replacing and what they are not.

The core trade-off is access versus substance. Synthetic instruments have dramatically lowered the barrier to price participation in private company growth, but they have not replicated the legal and economic substance of actual ownership.

A holder of SpaceX pre-IPO perps and a holder of SpaceX shares are not positioned equivalently. One holds a derivative that tracks implied valuation. The other holds a legal claim to a share of one of the most valuable companies ever built.

Why Synthetic Exposure to Private Companies Has Surged in 2026

The structural backdrop:

Companies are staying private far longer than historical norms. Jay Ritter's IPO dataset shows the median IPO age reached 14 years in 2024 – nearly double the 8-year median of the mid-1990s. The result is that most of a company's valuation growth now occurs before any public market access exists.

SpaceX was founded in 2002. OpenAI in 2015. Anthropic in 2021. None has ever traded on a public exchange, yet combined, their implied valuations run into the trillions.

The 2026 catalyst:

SpaceX's Nasdaq debut on June 12, 2026, targeting $135 per share and a $1.77 trillion valuation, is projected to be the largest public offering in history. The announcement triggered an immediate expansion of synthetic market infrastructure:

• Binance launched SpaceX perpetual futures in May 2026
• Coinbase International launched SpaceX Pre-IPO Perps on June 3, 2026, describing them as "a new asset class, built for this era of markets."
• OKX, Kraken, and Gate.io followed with their own pre-IPO perpetual offerings for SpaceX, OpenAI, and Anthropic
• DeFiLlama began tracking pre-IPO perp markets across Hyperliquid, Aster, Lighter, and ApeX, covering SpaceX (6 markets), OpenAI (3 markets), Anthropic (3 markets), and Quantinuum (2 markets)

The SpaceX SPCX contract alone accumulated over $2.2 billion in cumulative volume before the IPO date, across centralized and decentralized venues. [2]

Regulatory signal:

The SEC's January 2026 guidance did not shut down synthetic markets, but clarified their legal status. By establishing that third-party synthetic equity products fall under full securities and derivatives rules, the agency effectively legitimized the category while signaling tighter oversight ahead.

Risks of Synthetic Exposure to Private Companies

These risks differ meaningfully from those in traditional equity investing and standard crypto derivatives, and understanding them is essential before entering any position.

1. Funding rate drain (pre-IPO perps)

Perpetual futures require continuous funding rate payments between longs and shorts. If the contract trades at a persistent premium to the mark price, which is common when retail demand heavily skews long, holders of long positions pay ongoing fees to short holders. A position can lose value even when the underlying implied valuation moves in the right direction.

2. Oracle and mark price risk (pre-IPO perps)

The mark price for a private company's perp is estimated from secondary transactions, funding round data, or aggregated platform feeds. This introduces a degree of imprecision that does not exist in public equity derivatives.

While the Cerebras case demonstrated impressive accuracy (within 1.3% of the IPO open), this is a single data point, not a guarantee of systematic precision.

3. Issuer disavowal risk (SPV tokens)

A company can publicly state that any SPV acquiring its shares does so without authorization, and this statement can effectively collapse the value of tokens backed by those SPVs. This risk is binary: the token either retains its structural integrity or it does not. OpenAI and Anthropic's May 2026 disavowals demonstrated how quickly this can materialize.

4. Counterparty risk (SPV tokens and equity swaps)

SPV token holders are exposed to the SPV operator. If the SPV does not actually hold the shares it claims to hold, or if it becomes insolvent, token holders have limited recourse. Equity swap counterparty risk is mitigated by ISDA agreements and collateral arrangements, but it remains present and is particularly acute for non-standard private company reference assets.

5. Regulatory risk (all structures)

The legal landscape for synthetic private company exposure is still being defined. The SEC's January 2026 guidance tightened scrutiny significantly, and other jurisdictions are watching closely. A regulatory reclassification of a synthetic product can affect its tradability, settlement mechanics, or investor eligibility overnight.

6. IPO delay or cancellation risk

If a company delays its IPO or decides to remain private indefinitely, synthetic markets can dry up rapidly. Bid-ask spreads widen, funding rates become unfavorable, and liquidity deteriorates. A position that looked attractive at entry can become difficult or expensive to exit if the anticipated catalyst fails to materialize on schedule.

The Author’s Perspective: Who Should Consider Synthetic Exposure to Private Companies?

What synthetic exposure has actually created is a market for sentiment. When $2.2 billion in cumulative volume flows through SpaceX perpetual contracts before the IPO, that is $2.2 billion of bets on what SpaceX will be worth. The appeal of synthetic exposure is real. But the product being sold is price exposure, which behaves very differently from ownership when things get complicated – at IPO, at valuation revisions, and especially when a company decides to formally disavow the structures being used to reference it.

Synthetic exposure makes most sense for traders with a clear, time-bounded thesis on valuation and not for investors looking for the long-term ownership upside that private equity historically delivers. If you are entering a pre-IPO perp, you are taking a position on where the market will price the stock when it lists. That is a speculative trade, and it should be sized and managed accordingly.

The investors for whom synthetic exposure is genuinely useful are those who need price hedging, those testing a valuation thesis before committing to real equity through secondaries, and those in jurisdictions where direct IPO access is restricted or prohibited. For everyone else, the gap between "price exposure" and "ownership" is worth taking seriously before entering.

– BytebyByte, Cryptothreads.io

Sources and Further Reading

• ISDA – "Overview of OTC Equity Derivatives Markets: Use Cases and Recent Developments" https://www.isda.org/a/1IhgE/Overview-of-OTC-Equity-Derivatives-Markets-Use-Cases-and-Recent-Developments.pdf
• SEC – "Staff Statement on Tokenized Securities" (January 2026) https://www.sec.gov/news/statement/cfd-im-tm-tokenized-securities-20260129
• FB Ventures – "Why Companies Stay Private Longer and What It Means for Investors" (February 2026) https://www.fbventures.vc/post/why-companies-stay-private-longer
• Bocconi Students Investment Club – "A Primer on Equity Swaps" https://bsic.it/a-primer-on-equity-swaps/
• NAIC Capital Markets Bureau – "Derivatives Primer" https://content.naic.org/sites/default/files/capital-markets-primer-derivatives.pdf
• Talos / Coin Metrics – "State of the Network #367: Hyperliquid Pre-IPO Price Discovery on Crypto Rails" (June 2026) https://www.talos.com/insights/state-of-the-network-367
• CNBC – "Investors Can 'Buy' SpaceX Early with Coinbase Perpetual Futures on Pre-IPOs" (June 2026) https://www.cnbc.com/2026/06/04/investors-can-buy-spacex-early-with-coinbase-perpetual-futures-on-pre-ipos.html